Siga Technologies (SIGA) Free Cash Flow (2010 - 2025)
Siga Technologies' (SIGA) quarterly Free Cash Flow came in at -$10.1 million in Q3 2025, down 36.43% on a YoY basis from -$15.9 million in Q3 2024, and down 116.02% quarter-over-quarter from $63.1 million in Q2 2025.
Analysis
Siga Technologies (SIGA) Free Cash Flow (2010 - 2025) Analysis & Trends
Siga Technologies (SIGA) has reported Free Cash Flow for 16 consecutive years, with -$10.1 million the latest figure, recorded in Q3 2025.
- For the quarter ending Q3 2025, Free Cash Flow fell 36.43% year-over-year to -$10.1 million; the trailing twelve-month figure through Sep 2025 stood at $116.3 million (up 62.77% YoY), and the FY2024 full-year result was $48.7 million, down 48.6% from the prior year.
- Free Cash Flow slipped to -$10.1 million in Q3 2025 per SIGA's latest filing, from $63.1 million in the prior quarter.
- Across five years, Free Cash Flow topped out at $79.0 million in Q4 2023 and bottomed at -$10.1 million in Q3 2025.
- Historically, Free Cash Flow has averaged $13.5 million across 5 years, with a median of -$1.4 million in 2021.
- The widest YoY moves for Free Cash Flow: up 1276.47% in 2022, down 393.58% in 2022.
- Over 5 years, Free Cash Flow stood at $16.1 million in 2021, then plunged by 150.42% to -$8.1 million in 2022, then surged by 1074.95% to $79.0 million in 2023, then declined by 28.77% to $56.3 million in 2024, then sank by 117.95% to -$10.1 million in 2025.
- According to Business Quant data, Free Cash Flow over the past three periods registered -$10.1 million, $63.1 million, and $7.0 million for Q3 2025, Q2 2025, and Q1 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 643.26 Bn | 622.50 Bn | 17.26 Bn | 7.30 Bn |
| 2 | AbbVie | 443.31 Bn | 436.74 Bn | 12.70 Bn | 3.11 Bn |
| 3 | Merck | 364.74 Bn | 357.60 Bn | 12.21 Bn | 4.48 Bn |
| 4 | Novartis Ag | 266.46 Bn | 258.77 Bn | 11.24 Bn | 6.20 Bn |
| 5 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn | 302.00 Mn |
| 6 | Sanofi | 52.33 Bn | 44.95 Bn | 10.79 Bn | 3.44 Bn |
| 7 | Revolution Medicines | 43.79 Bn | 43.79 Bn | - | -389.61 Mn |
| 8 | Incyte | 25.23 Bn | 20.69 Bn | 1.57 Bn | 495.25 Mn |
| 9 | United Therapeutics | 21.67 Bn | 19.01 Bn | 683.80 Mn | 205.60 Mn |
| 10 | Siga Technologies | 220.19 Mn | 65.22 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | -10.10 Mn |
| Jun 30, 2025 | 63.08 Mn |
| Mar 31, 2025 | 7.04 Mn |
| Dec 31, 2024 | 56.29 Mn |
| Sep 30, 2024 | -7.41 Mn |
| Jun 30, 2024 | 5.95 Mn |
| Mar 31, 2024 | -6.12 Mn |
| Dec 31, 2023 | 79.03 Mn |
| Sep 30, 2023 | -5.10 Mn |
| Jun 30, 2023 | -3.60 Mn |
| Mar 31, 2023 | 24.45 Mn |
| Dec 31, 2022 | -8.11 Mn |
| Sep 30, 2022 | -4.78 Mn |
| Jun 30, 2022 | -2.21 Mn |
| Mar 31, 2022 | 56.71 Mn |
| Dec 31, 2021 | 16.08 Mn |
| Sep 30, 2021 | 1.63 Mn |
| Jun 30, 2021 | -1.44 Mn |
| Mar 31, 2021 | -4.82 Mn |
| Dec 31, 2020 | 45.95 Mn |